Trial represents first-ever CDC-sponsored clinical trial of vaccine delivered via “patch” technology and utilizes Micron’s first-in-class dissolvable microarray technologyResearch builds on ...

A high-tech acne patch cleared treated breakouts in just 7 days during a Korean clinical trial. Could this be the future of ...

Courtesy of CombiMatrix The research community's rapid acceptance of microarrays notwithstanding, technical challenges remain. Biochip developers continue to grapple with these issues while upgrading ...

DNA Microarray IndustryThe global DNA microarray Industry is projected to witness robust growth, with its valuation expected to increase from USD 4.1 billion in 2024 to USD 9.9 billion by 2034, ...

The Advances in Microarray Technology Conference, the fourth in the Select BioSciences AMT events, held in Barcelona May 7-8, 2008 was well attended, with more than 400 participants, around 40 ...

Research builds on Emory's research on influenza vaccines self-administered via Micron's microarray technology ATLANTA, June 16, 2025 (GLOBE NEWSWIRE) -- Emory University and Micron Biomedical today ...

Biolog, Inc. announced today that it has received another patent on its Phenotype MicroArray™ technology, extending the breadth and depth of its unique portfolio of intellectual property. Patent US ...

Two-stage pimple patches featuring arrowhead-shaped spikes provide targeted delivery of compounds, clearing pimples entirely ...

A team of researchers has designed a two-stage pimple patch set with an array of tiny spikes that grabs onto a pimple and ...